Key result
MYLIP genetic variants are linked to lipid and liver markers but not CVD outcomes.
Why the study?
Are genetic variants in MYLIP associated with cardiovascular disease and cardiometabolic risk factors in women?
Observational (n=266,500)
Yes
Are genetic variants in MYLIP associated with cardiovascular disease and cardiometabolic risk factors in women?
Answers are grounded in this paper and cite their sources.
Genetic variation in MYLIP is robustly associated with lipid, liver, and hematologic-related traits, and thyroid hormone regulation in women, supporting its role as a pleiotropic gene influencing metabolic pathways.
Background The MYLIP gene encodes myosin regulatory light chain-interacting protein, a key regulator of LDL receptor degradation and lipid metabolism. Variants within MYLIP have been associated with lipid traits, particularly LDL cholesterol and total cholesterol, in large-scale genetic studies. However, despite these established lipid associations, no direct link has been demonstrated between MYLIP variants and cardiovascular disease (CVD) outcomes. Emerging evidence also suggests sex-specific physiological effects of MYLIP variation, yet the broader cardiometabolic implications specifically in women remain incompletely understood. Purpose To investigate associations between genetic variation in MYLIP and CVD, cardiometabolic risk factors, and female-specific traits in women. Methods We analyzed data from 46,071 women in the Trøndelag Health Study (HUNT, Norway) and 220,429 women in the UK Biobank (UKB, United Kingdom). Genetic variants within ±50 kb of MYLIP were tested for association with CVD outcomes, biomarkers, and risk factors using SAIGE (for binary traits) and BOLT-LMM (for continuous traits). Multiple testing correction was applied using false discovery rate (FDR < 0.05) for discovery analyses, with Bonferroni correction for cross-cohort validation. Results No significant associations were observed between MYLIP variants and CVD outcomes after multiple testing correction, although suggestive associations were observed for hyperthyroidism, hypothyroidism, dilated and hypertrophic cardiomyopathy, myocardial infarction, stroke, coronary artery disease, and hypertension (Figure 1). In contrast, MYLIP-proximal variants were associated with 17 quantitative traits in HUNT (Figure 2), of which 10 (out of 11 available phenotypes) replicated in UKB. Replicated associations included lipid traits (LDL cholesterol, total cholesterol, triglycerides), thyroid-stimulating hormone, and liver enzymes (ASAT, ALAT, albumin), and hematologic markers (eosinophils, lymphocytes, nucleated red blood cells). Functional annotation revealed several missense variants potentially affecting lipid and liver function. Conclusions Genetic variation in MYLIP is robustly associated with lipid, liver, and hematologic-related traits, and with thyroid hormone regulation in women. While no direct association with CVD outcomes was observed, the findings support MYLIP as a pleiotropic gene influencing metabolic pathways relevant to cardiovascular health in women.
No takes yet. Share an insight, caveat, or question.
Klevjer et al. (2026) conducted an observational in Cardiovascular disease and cardiometabolic risk factors (n=266,500). Genetic variation in MYLIP was evaluated on CVD outcomes, biomarkers, and risk factors. Genetic variation in MYLIP was associated with 17 quantitative traits in HUNT, of which 10 replicated in UK Biobank, including lipid and liver markers, but not CVD outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: